Success Stories

Through a national payer program with Genemarkers, CPESN® pharmacies are paid a flat fee to collect patient DNA samples for testing and review results with patients. The personalized medicine approach can indicate how a patient might respond to a particular treatment or which medication may work best for an individual.

Medicaid MCO coverage of adherence packaging and delivery through CPESN® Nebraska has allowed Elmwood Pharmacy to expand the service. Pharmacist Crystal Pfeifer says that's a plus for patients and for the pharmacy.

Clinical Screening for Major Depression Disorder treatment study proved a good opportunity for pharmacies in the St. Louis, MO metro area to boost patient engagement and pharmacy revenue. Tyler Taylor CPESN Missouri regional facilitator, said the RxE2 program paid pharmacies for all steps regardless of outcome, saying that's "... very helpful in a world where we don't get paid for our work very often."

Expansion of a Medicaid MCO program allows CPESN® Pennsylvania pharmacist to add diabetes disease management to services they provide to Medicaid patients. Additionally, they will now be paid for Social Determinants of Health screenings and referrals.

Laura Rhodes, CPESN USA Regional PPP Lead, describes how quality performance by CPESN® Florida pharmacies in a 2022 Medicaid adherence program has led to renewal in that state with opportunities for nearly three times as many pharmacies, and expansion to Texas where almost 90 CPESN pharmacies will be able to participate. The two networks trained together last week, preparing for the renewal and rollout in Texas.

Helping Medicaid patients diagnosed with diabetes or hypertension control their blood pressure or lower their HbA1c is the focus goal of a broad statewide managed Medicaid program available to the nearly 200 CPESN® Pennsylvania pharmacies across the state. Early patient outcomes include significantly lowered HbA1C levels and impactful referrals to other community providers based on social determinants of health surveys.

Brianna Chesser, a pharmacist with Best Value Ridglea Pharmacy in Fort Worth, shares examples of how CPESN® Texas pharmacies are helping to improve the health of diabetes and CVD patients enrolled in a managed Medicaid program.

Sarah Covert, a pharmacist with McCoy-Tygart Drug in Sheridan, AR describes how her team works with rural patients enrolled in a Medicaid MCO plan. Understanding and addressing health inequities is part of her efforts to improve medication adherence.

CPESN® Hawaii pharmacies reached out to Medicare programs with medication adherence gaps for treating diabetes, hypertension, and other chronic illnesses. In addition to meeting year-end goals for the health plan, the pharmacies coached patients to support their longer term health outcomes.

Rebecca Wagers, CPESN® NET Managing Network Facilitator, says the Emergent ACO Special Purpose Partnership has expanded to seven states and that CPESN pharmacies have submiitted more than 50,000 eCare plans. And that's just the start.

Eric Hughes, CPESN® Arkansas Managing Network Facilitator, describes one of three new RxE2 clinical trial recruitment recruitment opportunities for 2023. In this multi-state recruitment, pharamcies in several networks review prescribing records to identify patients with treatment-resistent depression. Some patients with a specific gene marker may participate in an investigational drug study. It's a payable opportunity for patients, and creates network revenue as well.

Community pharmacies educating patients - especially in underserved communities - about health conditions and access to clinical trials is the focus of a partnership between CPESN® USA and Inside Edge Consulting Group.

Cold calls to the South Dakota Department of Health five years ago opened the way for a successful hypertension management program. The small network in a rural state has tripled in size and delivered cardiovascular risk reduction programs to more than 150 patients.

CPESN® Hawaii credits a unified marketing front, persistence, and leveraging COVID-19 opportunities for that network's steady growth and payer contracts.

CPESN® USA PPP Regional Lead Laura Rhodes describes how pharmacies in CPESN® Virginia and CPESN® Florida collectively engaged dually eligible patients in a quick turn program to obtain blood pressure readings and help the MCO close care gaps. Looking forward, Rhodes says with an earlier start in the year, CPESN community pharmacy efforts can deliver greater impact for MCO payers.

Grant-funded Nicotene Replacement Therapy program helped CPESN® California pharmacies refine workflows and create patient awareness of health services under expanded Medi-Cal coverage. Pharmacy Support Staff were critical to program success.

Breah Schibi of Bowen Pharmacy in Parsons, Kansas describes her positive experience with offering self-administered early cognitive testing to 65+ pharmacy patients. Bowen is one of 29 CPESN pharmacies selected for the program in partership with Avant Institute and funded by the global Davos Alzheimer's Initiative.

G&M Pharmacy in Oxford, MS is one of five CPESN community pharmacies to complete a multi-state pilot program with RxE2 where deidentified patient gender, race, ethnic data was collected and reported. The program demonstrates how the community pharmacy relationship with patients can help expand access to clinical trials for underrepresented ethnic and racial populations.

RxSelect CPESN® the Oklahoma local network provides comprehensive and targeted medication reviews for Medicaid patients at a high risk for return hospitalization or emergency visits. The result = lower total cost of care.

CPESN® Texas pharmacist Traci Bayer, co-owner of Hillcrest Pharmacy in Vernon, Texas, describes a patient's success in reaching blood pressure goals as part of a grant-funded remote patient monitoring pilot program.

CPESN® Maryland has it's first contract to provide high-touch clinical services to Medicaid patients with diabetes and asthma.

A shortage of lifestyle change coaches to implement CDC's Diabetes Prevention Program led CPESN Alabama leaders to offer free coach training. Lead Luminary Patrick Devereux says the network believes that having 15 certified coaches will lead to Medicare MCO and commercial payer opportunities.

Documentation of a blood pressure reading for nearly 1,000 patients by the end of year is the goal for 100 CPESN Florida pharmacies as part of a new managed MCO program. Laura Rhodes, Managing Network Facilitator, hopes the program will lead to more opportunities in 2023.

CPESN® West Virginia pharmacist Amber Conrad describes how the extension of a grant-funded Naloxone dispensing program allows her network's pharmacies to serve their communities. The program is funded through the West Virginia Drug Invention Institute and the West Virginia Department of Health.

Improved medication adherence for patients with diabetes is the goal of a new Medicaid managed care pilot program for CPESN North Carolina pharamcists. Amina Abubakar, owner of Avant Pharmacy & Wellness in Charlotte and a North Carolina luminary, describes the network opportunity.

Increased adherence to oral anticoagulants in Medicare AFib patients is the goal of a new multi-partner program for CPESN® North Carolina. The collaborative includes the CPESN Clinically Integrated Network (CIN), a pharmaceutical manufacturer, a health insurer, and a large health system. Luminary Jessi Stout, owner of Table Rock Pharmacy in Morganton, NC, describes the opportunity.

Eric Hughes, project manager with CPESN® Arkansas, describes a new contract for that network with CSS Health. Network pharmacies will provide comprehensive and targeted medication reviews for identified patients with reporting through the CSS MTM platform. 36 pharmacies are enrolled and other interested Arkansas network pharmacies should contact Eric at ehughes@cpesn.com.

CPESN Texas Pharmacist Laura Temple, owner of Laura's Pharmacy in Azle, TX, describes how using Asthma Severity Technology as part of a network pilot program helped her adjust medications and improve the outcome for a patient.

With the 4th-year renewal of a partnership with the South Dakota Dept. of Health, CPESN South Dakota pharmacists will take the successful cardiovascular disease program and their services into the communities where they will educate and screen for CVD risk.

A new contract with a clinical trial research group offers CPESN Utah pharmacies an opportunity to identify and refer qualifying patients for participation in drug development research.